Trump’s promise to make IVF covered by insurance or government payment does not reflect what his administration has actually implemented. While Trump stated during his 2024 campaign that “under the Trump administration, your government will pay for, or your insurance company will be mandated to pay for, all costs associated with IVF treatment,” the reality is far narrower. His February 2025 executive order authorized employers to offer fertility benefits as “excepted benefits”—similar to dental or vision coverage—but created no federal mandate, no federal subsidies, and no requirement that employers participate. For a couple pursuing IVF treatment, this distinction matters enormously: a husband and wife with employer fertility coverage through an excepted benefit HRA would receive only $2,150 per year toward IVF costs, while a single IVF cycle typically costs $15,000 to $20,000.
The Trump administration’s approach runs directly into a specific limitation of ERISA—the Employee Retirement Income Security Act—that fundamentally constrains what employers can be required to cover. When fertility benefits are offered as excepted benefits, they fall outside essential health benefits requirements, annual out-of-pocket maximums, and mental health parity rules. This legal framework exists to give employers flexibility, but it also means that women and families counting on employer-based IVF coverage cannot rely on the same consumer protections that apply to major health insurance. Understanding these ERISA limits is essential to evaluating whether Trump’s IVF initiative will actually reduce the financial burden on American families pursuing fertility treatment.
Table of Contents
- What Did Trump Promise During His Campaign, and What Has His Administration Actually Delivered?
- What Is ERISA’s $2,150 Cap, and Why Does It Matter for IVF Coverage?
- How Does ERISA Preemption Allow Self-Insured Employers to Ignore State IVF Mandates?
- What Are the Limits of the TrumpRx.gov Medication Discount Program?
- Why Excepted Benefit Status Removes Protections That Apply to Regular Health Insurance
- How Does Excepted Benefit Fertility Coverage Compare to State Mandates?
- What Is the Path Forward for Federal IVF Policy?
- Conclusion
What Did Trump Promise During His Campaign, and What Has His Administration Actually Delivered?
During an August 2024 interview, trump stated unequivocally that government or insurance companies would be “mandated to pay for, all costs associated with IVF treatment.” When pressed on whether insurance companies would be required to pay for IVF “under a mandate,” Trump said “yes.” These statements created expectations that a Trump administration would impose a federal mandate on employers and insurers—similar to state-level IVF mandates that have been enacted in more than a dozen states over the past two decades. However, the executive order signed in February 2025 deliberately avoided this approach. Instead of a mandate, the Trump administration issued guidance allowing employers to offer fertility coverage as an excepted benefit—a category of health benefits that sits outside the main health insurance plan.
This is a voluntary option, not a requirement. Employers can choose to offer it, but they face no penalty for declining. The executive order also did not create federal subsidies for IVF treatment, did not introduce new tax incentives to help families afford treatment, and did not expand Medicaid coverage of fertility services. What the administration did create was the TrumpRx.gov platform, launched February 5, 2026, which offers fertility medications at discounted prices—specifically, medications like Gonal-f, Ovidrel, and Cetrotide at 84% off list prices. This addresses medication costs only, not the full cost of IVF cycles, which includes clinic fees, procedures, and monitoring visits that medications represent only a portion of.
What Is ERISA’s $2,150 Cap, and Why Does It Matter for IVF Coverage?
Under ERISA, when employers offer fertility benefits as excepted benefits, they can contribute to a Health Reimbursement Account (HRA) designated for fertility treatment. However, there is a strict annual cap: employer contributions to these fertility HRAs cannot exceed $2,150 per year. To understand what this means in practical terms, consider a woman who requires two rounds of IVF: the first cycle might cost $18,000, and if unsuccessful, a second round might cost another $15,000. With the $2,150 annual limit, that employer contribution covers approximately one-tenth of the cost of a single IVF cycle. The couple or individual would be responsible for the remaining $32,850.
This $2,150 cap exists because ERISA treats excepted benefits as a separate category from comprehensive health insurance. The cap is not arbitrary—it reflects a congressional decision to allow employers to offer these benefits while limiting the employer’s financial obligation. Employees can contribute their own money to these accounts beyond the employer contribution, but the employer-funded portion is hard-capped. This limitation is particularly consequential for families with middle incomes who cannot absorb tens of thousands of dollars in out-of-pocket IVF costs but whose employers might offer this excepted benefit as a modest fertility benefit. The cap creates a false sense of coverage: an employer might advertise “fertility benefits” while the actual benefit amounts to less than 15% of a typical IVF cycle cost.
How Does ERISA Preemption Allow Self-Insured Employers to Ignore State IVF Mandates?
More than a dozen states have enacted fertility coverage mandates requiring insurers to cover ivf treatment. States like New York, California, Illinois, and others have passed laws requiring health insurance plans to cover fertility services, including IVF. However, these state mandates do not apply to self-insured employers—companies that pay their employees’ health claims directly rather than purchasing health insurance from a carrier. ERISA preempts state insurance law for self-insured plans, meaning a large self-insured employer in New York does not have to comply with New York’s fertility coverage mandate.
This creates a significant coverage gap: an employee at a self-insured company in a state with a strong IVF mandate receives no IVF coverage from that mandate, while an employee at an insured company in the same state does. This preemption affects millions of workers. Self-insured plans cover roughly 60% of Americans with employer-based health insurance, according to industry data. A woman working at a Fortune 500 company with a self-insured plan cannot rely on her state’s IVF mandate, even if that state has mandated coverage. The only way she would receive coverage is if her employer voluntarily chose to offer it, or if the federal government imposed a mandate—which Trump’s executive order explicitly did not do. The practical consequence is that two women in the same state, both wanting IVF treatment, might have vastly different coverage depending on whether their employer is self-insured or uses a carrier. This inequality persists under the current Trump administration framework.
What Are the Limits of the TrumpRx.gov Medication Discount Program?
The TrumpRx.gov platform launched in February 2026 offers fertility medications at 84% discounts off list prices. For someone purchasing Gonal-f, a gonadotropin commonly used in IVF cycles, this can represent substantial savings—potentially hundreds of dollars per month if purchased at full list price. However, this program addresses only a portion of IVF costs. A typical IVF cycle includes medications, but also clinic fees, ultrasound monitoring, egg retrieval procedures, embryo transfer, and sometimes additional services like genetic testing or egg freezing. These procedural and facility costs typically dwarf medication costs.
Consider a concrete example: a clinic charges $12,000 for an IVF cycle’s procedural component (retrieval, transfer, and monitoring), with medications adding another $3,000 to $5,000. An 84% discount on medications might reduce that $3,000 to $5,000 component to $480 to $800, but leaves the $12,000 clinic fee untouched. The TrumpRx.gov program is valuable for patients purchasing fertility medications out-of-pocket, but it is not a substitute for comprehensive IVF coverage. For families who cannot afford the full cost of IVF in the first place, saving money on medications alone does not make treatment financially accessible.
Why Excepted Benefit Status Removes Protections That Apply to Regular Health Insurance
When fertility benefits are offered as excepted benefits, they fall outside several key protections that apply to standard health insurance plans. Excepted benefits are exempt from requirements to cover mental health services on equal terms with physical health (mental health parity rules). This means an excepted benefit IVF plan does not have to provide mental health counseling before, during, or after treatment—a service that many fertility clinics and patient advocacy groups consider essential for managing the emotional impact of infertility. Additionally, excepted benefits are exempt from annual out-of-pocket maximum requirements that apply to major health insurance. A traditional health plan must have an annual out-of-pocket maximum (currently around $9,100 for individuals and $18,200 for families), but an excepted benefit has no such requirement.
The most significant protection removed is the requirement to cover essential health benefits. Standard health insurance plans must cover preventive care without cost-sharing and must provide certain essential services. Excepted benefits have no such obligations. This means that an excepted benefit fertility HRA could theoretically reimburse only certain procedures or services while excluding others, with no regulatory requirement for comprehensive coverage. For employees, the warning is clear: excepted benefit fertility coverage is not interchangeable with traditional health insurance coverage of infertility. It is a limited, supplemental benefit that offers no guarantees about breadth of coverage or consumer protections.
How Does Excepted Benefit Fertility Coverage Compare to State Mandates?
States with fertility coverage mandates typically require health insurance plans to cover infertility diagnosis and treatment, including IVF, with minimal or no waiting periods. The scope of state mandates varies, but many require coverage without annual limits or high out-of-pocket costs. For example, New York’s mandate requires coverage of up to four IVF cycles per lifetime, with specific limits on what patients must pay out-of-pocket. By contrast, an excepted benefit HRA capped at $2,150 per year cannot come close to matching a four-cycle mandate.
A four-cycle mandate might provide access to $60,000 to $80,000 worth of IVF coverage, while the excepted benefit provides $2,150. The Trump administration’s excepted benefit approach is fundamentally weaker than existing state mandates. An employee in a state with a strong IVF mandate, covered by an insured health plan, has stronger fertility coverage than an employee at a self-insured company in the same state—or than an employee anywhere in the country relying solely on an excepted benefit fertility HRA. This creates a patchwork of coverage that depends on multiple factors: whether the state has a mandate, whether the employer is self-insured or insured, and whether the employer voluntarily chose to offer an excepted benefit. Trump’s promise that insurance companies would be mandated to pay for all IVF costs has not materialized.
What Is the Path Forward for Federal IVF Policy?
The Trump administration’s current approach to IVF coverage relies on voluntary employer action and medication discounts rather than federal mandates or comprehensive coverage requirements. Should Congress decide to act, it could impose a federal IVF coverage mandate that would override ERISA’s current limits and eliminate the self-insured employer loophole. Alternatively, Congress could increase the annual cap on excepted benefit HRA contributions for fertility treatment, though this would still fall short of comprehensive coverage. The medication discount program through TrumpRx.gov may expand or evolve, but without changes to the underlying insurance framework, it cannot replace the need for affordable access to clinic procedures.
Looking ahead, the fertility coverage landscape remains fragmented. Women and families seeking IVF treatment should not assume that Trump’s campaign promises have been fulfilled through executive action. Instead, they should verify their employer’s actual fertility coverage, check whether their state has an IVF mandate that might apply to their plan, and research the specifics of any excepted benefit HRA offered. The gap between campaign rhetoric and policy reality is substantial, and understanding ERISA’s limitations is essential to making informed decisions about whether fertility treatment is affordable under their current health plan.
Conclusion
Trump promised that the federal government and insurance companies would pay for all costs of IVF treatment. In reality, his February 2025 executive order authorized voluntary employer excepted benefits capped at $2,150 per year, launched a medication discount platform offering 84% off fertility drugs, and created no federal mandate requiring employers or insurers to cover IVF. The ERISA limit on excepted benefit HRA contributions means that most families cannot rely on employer-based fertility coverage to pay for full IVF treatment, which typically costs $15,000 to $20,000 per cycle. Self-insured employers, covering 60% of workers with employer health insurance, remain exempt from state IVF mandates, further limiting federal and state-level protection for many Americans seeking fertility treatment. For families considering IVF treatment, the critical first step is understanding what coverage actually exists.
If you have an employer health plan, ask whether it includes excepted benefit fertility coverage and, if so, what the annual HRA limit is. If you live in a state with an IVF mandate, verify that your plan is subject to it (not self-insured). Research the TrumpRx.gov medication discount program to understand potential savings on drugs. Most importantly, do not rely on the promise that Trump’s administration has mandated IVF coverage by insurance companies. That mandate does not exist, and the actual policy framework remains far narrower than the campaign rhetoric suggested.